For the quarter ending 2026-03-31.
| Income Statement | 2026-03-31 | |||
|---|---|---|---|---|
| General and administrative | 805,363 | |||
| Research and development | 438,240 | |||
| Total operating expenses | 1,243,603 | |||
| Loss from operations | -1,243,603 | |||
| Interest income | 173 | |||
| Net loss | -1,243,430 | |||
| Basic EPS | -0.07 | |||
| Diluted EPS | -0.07 | |||
| Basic Average Shares | 18,512,351 | |||
| Diluted Average Shares | 18,512,351 | |||
Palomino Laboratories Inc. (PALX)
Palomino Laboratories Inc. (PALX)